Puma Biotechnology (PBYI) Treasury Shares (2014 - 2026)

Puma Biotechnology has reported Treasury Shares for 13 years, with the latest figure at $2.0 million in Q1 2026.

• For the quarter ending Q1 2026, Treasury Shares rose 8.63% year-over-year to $2.0 million; the trailing twelve-month figure through Mar 2026 stood at $2.0 million (up 8.63% YoY), and the FY2025 full-year result was $1.3 million, up 3.53% from the prior year.
• Treasury Shares for Q1 2026 stood at $2.0 million, up from $1.3 million in the prior quarter.
• The five-year high for Treasury Shares was $2.4 million in Q1 2023, with the low at $1.3 million in Q4 2024.
• Historically, Treasury Shares has averaged $1.8 million across 5 years, with a median of $1.8 million in 2025.
• Annual changes were most pronounced in 2023 — Treasury Shares rose 24.33% — and 2024, when it dropped 22.69%.
• Puma Biotechnology's Treasury Shares stood at $1.5 million in 2022, then grew by 8.2% to $1.6 million in 2023, then fell by 20.65% to $1.3 million in 2024, then climbed by 3.53% to $1.3 million in 2025, then soared by 51.17% to $2.0 million in 2026.
• The last three Treasury Shares figures came in at $2.0 million (Q1 2026), $1.3 million (Q4 2025), and $1.4 million (Q3 2025), per Business Quant data.